Investigational Site — Nashville, Tennessee

Investigational Site is a clinical research site located in Nashville, Tennessee, United States 37205.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Site has participated in 13 clinical trials with 2 currently active.

Therapeutic areas: Rheumatoid Arthritis, Fallopian Tube Cancer, Ovarian Cancer.

Sponsors: Ablynx, a Sanofi company, Genentech, Inc., Novaliq GmbH.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site?

Investigational Site has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site conducted?

Investigational Site has 13 clinical trials on record, with 2 currently active. Their work covers Rheumatoid Arthritis, Fallopian Tube Cancer, Ovarian Cancer.

Is Investigational Site accredited by Crixeo Health?

Yes — Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.